Maharashtra, India

Thankachen Byju Nellithanath



 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: A Spotlight on Inventor Thankachen Byju Nellithanath

Introduction

Thankachen Byju Nellithanath, an innovative inventor based in Maharashtra, India, has made significant strides in the pharmaceutical field. She holds a patent that contributes to the enhanced bioavailability of poorly water-soluble drugs, showcasing her dedication to improving health outcomes through scientific ingenuity.

Latest Patents

Thankachen's notable patent focuses on a novel pharmaceutical composition aimed at enhancing the aqueous dissolution of drugs with poor solubility. The specific invention is an oral pharmaceutical composition that includes the antiparasitic and antipneumocystic drug Atovaquone, either alone or in combination with Proguanil. This advancement is crucial in addressing the challenges posed by drug solubility, thereby potentially improving therapeutic effectiveness for patients.

Career Highlights

Currently, Thankachen is associated with Ipca Laboratories Limited, where she leverages her expertise in pharmaceutical development. Her role contributes significantly to the company's innovative projects and the advancement of healthcare solutions.

Collaborations

Throughout her career, Thankachen has collaborated with fellow professionals, including Ashok Kumar and Dharmendra Singh. Working alongside these colleagues has enabled her to enhance her projects and integrate diverse expertise into her inventions.

Conclusion

Thankachen Byju Nellithanath exemplifies the spirit of innovation in the pharmaceutical industry. Through her patent and collaborative efforts, she continues to pave the way for advancements in drug formulation, addressing critical needs in medical treatments. Her work is a testament to the impact that dedicated inventors can have in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…